Cited 13 time in
Metformin-induced encephalopathy without lactic acidosis in a patient with contraindication for metformin
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Jung, Eun Young | - |
| dc.contributor.author | Cho, Hyun Seop | - |
| dc.contributor.author | Seo, Jong Woo | - |
| dc.contributor.author | Kim, Dong Wook | - |
| dc.contributor.author | Kim, Hyun-Jung | - |
| dc.contributor.author | Chang, Se-Ho | - |
| dc.contributor.author | Park, Dong Jun | - |
| dc.date.accessioned | 2022-12-27T05:18:37Z | - |
| dc.date.available | 2022-12-27T05:18:37Z | - |
| dc.date.issued | 2009-04 | - |
| dc.identifier.issn | 1492-7535 | - |
| dc.identifier.issn | 1542-4758 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/26353 | - |
| dc.description.abstract | A 51-year-old Korean man with end-stage renal disease and who was on intermittent hemodialysis was admitted with progressive dysarthria, gait disturbance, and myoclonus. The liver function tests and the electrolyte and arterial gas analyses were normal. The Magnetic resonance imaging scan showed a diffuse symmetric high signal intensity in the basal ganglia on the T2-weighted image. After a thorough history taking, we knew that he had been treated with metformin for 3 months at other hospital without our hospitals staff's knowledge. After stopping the metformin, the patient's neurologic signs and symptoms disappeared and the Magnetic resonance imaging findings after 20 days were markedly improved. | - |
| dc.format.extent | 4 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | WILEY | - |
| dc.title | Metformin-induced encephalopathy without lactic acidosis in a patient with contraindication for metformin | - |
| dc.type | Article | - |
| dc.publisher.location | 미국 | - |
| dc.identifier.doi | 10.1111/j.1542-4758.2009.00358.x | - |
| dc.identifier.scopusid | 2-s2.0-65449122761 | - |
| dc.identifier.wosid | 000265425700006 | - |
| dc.identifier.bibliographicCitation | HEMODIALYSIS INTERNATIONAL, v.13, no.2, pp 172 - 175 | - |
| dc.citation.title | HEMODIALYSIS INTERNATIONAL | - |
| dc.citation.volume | 13 | - |
| dc.citation.number | 2 | - |
| dc.citation.startPage | 172 | - |
| dc.citation.endPage | 175 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Urology & Nephrology | - |
| dc.relation.journalWebOfScienceCategory | Urology & Nephrology | - |
| dc.subject.keywordPlus | BICARBONATE HEMODIALYSIS | - |
| dc.subject.keywordAuthor | Metformin | - |
| dc.subject.keywordAuthor | encephalopathy | - |
| dc.subject.keywordAuthor | hemodialysis | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
